| Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis A Serra, J Derwenskus, DL Downey, RJ Leigh Journal of neurology 250, 569-575, 2003 | 103 | 2003 |
| Current disease‐modifying treatment of multiple sclerosis J Derwenskus Mount Sinai Journal of Medicine: A Journal of Translational and Personalized …, 2011 | 92 | 2011 |
| Abnormal eye movements predict disability in ms: two‐year follow‐up J Derwenskus, JC Rucker, A Serra, JS Stahl, DL Downey, NL Adams, ... Annals of the New York Academy of Sciences 1039 (1), 521-523, 2005 | 71 | 2005 |
| Saccadic and vestibular abnormalities in multiple sclerosis: sensitive clinical signs of brainstem and cerebellar involvement DL Downey, JS Stahl, R Bhidayasiri, J Derwenskus, NL Adams, RL Ruff, ... Annals of the New York Academy of Sciences 956 (1), 438-440, 2002 | 65 | 2002 |
| Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years J Oh, A Achiron, EG Celius, C Chambers, J Derwenskus, V Devonshire, ... Multiple Sclerosis and Related Disorders 43, 102146, 2020 | 26 | 2020 |
| Future treatment approaches to multiple sclerosis J Derwenskus, FD Lublin Handbook of Clinical Neurology 122, 563-577, 2014 | 23 | 2014 |
| Use of interferon-beta in the treatment of multiple sclerosis J Derwenskus¹, FD Lublin Multiple Sclerosis and Demyelinating Diseases 98, 257, 2006 | 9 | 2006 |
| Serious adverse events (SAE), autoimmunity (AI), and infections following alemtuzumab (ALE) therapy in a large, high disability, treatment-refractory MS clinic cohort RS Ghodasara, SRS Smith, M Mosley, R Morgan, M Bower, L Kagan, ... MULTIPLE SCLEROSIS JOURNAL 22, 617-618, 2016 | 5 | 2016 |
| Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis ZM Hernández, BA Cohen, J Derwenskus Multiple Sclerosis and Related Disorders 1 (4), 202-203, 2012 | 5 | 2012 |
| Clinically silent multiple sclerosis: description of a patient cohort without symptoms typical of MS but abnormal brain magnetic resonance imaging J Derwenskus, BA Cohen MULTIPLE SCLEROSIS 13 (9), 1226-1227, 2007 | 5 | 2007 |
| Partially thrombosed aneurysm and stroke OO Zaidat, J Derwenskus, JI Suarez, WR Selman Neurology 63 (7), 1285-1285, 2004 | 3 | 2004 |
| Paramagnetic rim lesions and the central vein sign: Characterizing multiple sclerosis imaging markers MA Clarke, R Cheek, HF Kazimuddin, B Hernandez, R Clarke, ... Journal of Neuroimaging 34 (1), 86-94, 2024 | 1 | 2024 |
| Paramagnetic rims in treatment naïve persons around the time of multiple sclerosis diagnosis M Clarke, R Cheek, R Clarke, C McKnight, J Derwenskus, J Eaton, R Fan, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 409-410, 2021 | 1 | 2021 |
| Spinal Cord Injury and Related Diseases J Derwenskus, OO Zaidat Critical Care Neurology and Neurosurgery, 417-432, 2004 | 1 | 2004 |
| Paramagnetic Rims in Treatment Naïve Persons Around the Time of Multiple Sclerosis Diagnosis (S26. 008) M Clarke, R Cheek, R Clarke, C McKnight, J Derwenskus, J Eaton, R Fan, ... Neurology 98 (18_supplement), 255, 2022 | | 2022 |
| Paramagnetic RIMS in Treatment Naive Persons at the Time of Multiple Sclerosis Diagnosis MA Clarke, C McKnight, J Derwenskus, K O'Grady, K Yoon, I Oguz, ... MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 71-71, 2021 | | 2021 |
| Pregnancy Outcomes in Alemtuzumab-treated Patients With RRMS in the Phase 2 and 3 Clinical Development Program Over 16 Years J Oh, EG Celius, C Chambers, J Derwenskus, V Devonshire, K Hellwig, ... 2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2019 | | 2019 |
| Postpartum relapse after first on-study pregnancy in RRMS patients treated with alemtuzumab in the phase 2 and 3 clinical development program over 8 years EG Celius, A Achiron, DAS Compston, J Derwenskus, V Devonshire, ... Multiple Sclerosis Journal 25, 395-396, 2019 | | 2019 |
| Alemtuzumab causes significant, transient, post-infusion thrombocytopenia and other cytopenias following initial and subsequent courses RS Ghodasara, RA Morgan, MC Mosley, MG Bower, LA Kagan, D Kantor, ... ACTRIMS Forum 2016, 2016 | | 2016 |
| Characteristics of demyelinating disease in Latin Americans ZM Hernandez, JA Derwenskus MULTIPLE SCLEROSIS JOURNAL 16 (8), 1005-1006, 2010 | | 2010 |
